Michael Stanley Rosol Navidea Biopharmaceuticals, Inc. (NAVB) insider trading activity

NAVB Quotes by TradingView

Michael Stanley Rosol is Chief Medical Officer of NAVIDEA BIOPHARMACEUTICALS, INC.. Currently has a direct ownership of 55,725 shares of NAVB, which is worth approximately $0. The most recent transaction as insider was on Sep 09, 2022, when has been sold 41,150 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 55.7K
0% 3M change
0% 12M change
Total Value Held $0

Michael Stanley Rosol Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 09 2022
BUY
Grant, award, or other acquisition
-
41,150 Added 42.48%
55,725 Common Stock
Jan 14 2022
BUY
Grant, award, or other acquisition
-
7,728 Added 34.65%
14,575 Common Stock
MSR

Michael Stanley Rosol

Chief Medical Officer
Dublin, OH

Track Institutional and Insider Activities on NAVB

Follow NAVIDEA BIOPHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NAVB shares.

Notify only if

Insider Trading

Get notified when an Navidea Biopharmaceuticals, Inc. insider buys or sells NAVB shares.

Notify only if

News

Receive news related to NAVIDEA BIOPHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NAVB